Natural Milk Thistle Extract Powder (Silybummarianum L. Gaertn) is a herbaceous plant of the genus Silybum, Asteraceae, native to Southern Europe and North Africa. Milk thistle is a European folk medicinal herb, and its extract was used in the West as early as the 4th century BC for the treatment of liver and gallbladder diseases. Silymarin (silymarin) is a new type of flavonoids extracted from the seeds of Silymarin. The main components are silybin, isosilybin, silymarin and silymarin. Among them, silybin has the highest content and the strongest biological activity. Basic and clinical studies have confirmed that silibinin has the functions of protecting liver, anti-inflammatory, immune regulation, lowering blood lipids and anti-oxidation. Therefore, it is widely used in the treatment of various liver diseases by countries all over the world.
Animal experiments have confirmed that milk thistle preparations have a protective effect on liver damage caused by carbon tetrachloride, galactosamine, alcohols and other liver toxins, and can also improve the pathological changes of non-alcoholic fatty liver disease. The liver protection mechanism of silymarin is summarized as follows.
Anti-oxidize effect:
Silymarin which is in Natural Milk Thistle Extract Powder can protect liver cell membranes by resisting lipid peroxidation and maintain the fluidity of cell membranes; it can also inhibit the release of superoxide anions from neutrophils to reduce liver cell damage caused by inflammatory cells. Studies have also shown that silibinin can increase the expression of superoxide dismutase (SOD) in lymphocytes in mice with chronic alcoholic liver disease, thereby playing an antioxidant role. Moreover, there are also reports that silybin can reduce the production of reactive oxygen species (ROS) and malondialdehyde (MDA).
Anti-liver fibrosis effect:
A number of studies have confirmed that silymarin can achieve anti-fibrosis effects through anti-oxidation and direct inhibition of the activation of various cytokines on hepatic stellate cells (HSC).
Lipid-lowering effect:
Experiments in mice have confirmed that silibinin can reduce the levels of triglycerides (TG) in the liver and the levels of serum TG and total cholesterol (TCh). And these animal experiments also show that after the intervention of silibinin, the liver pathology (such as steatosis, inflammation and ballooning of liver cells) has been improved to varying degrees. Studies have also suggested that the drug can reduce the weight of test animals.
